These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Increased calcification in osteoprotegerin-deficient smooth muscle cells: Dependence on receptor activator of NF-κB ligand and interleukin 6. Callegari A, Coons ML, Ricks JL, Rosenfeld ME, Scatena M. J Vasc Res; 2014; 51(2):118-31. PubMed ID: 24642764 [Abstract] [Full Text] [Related]
3. RANKL increases vascular smooth muscle cell calcification through a RANK-BMP4-dependent pathway. Panizo S, Cardus A, Encinas M, Parisi E, Valcheva P, López-Ongil S, Coll B, Fernandez E, Valdivielso JM. Circ Res; 2009 May 08; 104(9):1041-8. PubMed ID: 19325147 [Abstract] [Full Text] [Related]
4. The function and meaning of receptor activator of NF-κB ligand in arterial calcification. Nie B, Zhou SQ, Fang X, Zhang SY, Guan SM. J Huazhong Univ Sci Technolog Med Sci; 2015 Oct 08; 35(5):666-671. PubMed ID: 26489619 [Abstract] [Full Text] [Related]
5. RANKL, but Not R-Spondins, Is Involved in Vascular Smooth Muscle Cell Calcification through LGR4 Interaction. Fernández-Villabrille S, Martín-Vírgala J, Martín-Carro B, Baena-Huerta F, González-García N, Gil-Peña H, Rodríguez-García M, Fernández-Gómez JM, Fernández-Martín JL, Alonso-Montes C, Naves-Díaz M, Carrillo-López N, Panizo S. Int J Mol Sci; 2024 May 24; 25(11):. PubMed ID: 38891922 [Abstract] [Full Text] [Related]
7. TRAIL-deficiency accelerates vascular calcification in atherosclerosis via modulation of RANKL. Di Bartolo BA, Cartland SP, Harith HH, Bobryshev YV, Schoppet M, Kavurma MM. PLoS One; 2013 May 24; 8(9):e74211. PubMed ID: 24040204 [Abstract] [Full Text] [Related]
8. Role of Wnt/β-Catenin Pathway in the Arterial Medial Calcification and Its Effect on the OPG/RANKL System. Nie B, Zhang SY, Guan SM, Zhou SQ, Fang X. Curr Med Sci; 2019 Feb 24; 39(1):28-36. PubMed ID: 30868488 [Abstract] [Full Text] [Related]
10. TLR2 Promotes Vascular Smooth Muscle Cell Chondrogenic Differentiation and Consequent Calcification via the Concerted Actions of Osteoprotegerin Suppression and IL-6-Mediated RANKL Induction. Lee GL, Yeh CC, Wu JY, Lin HC, Wang YF, Kuo YY, Hsieh YT, Hsu YJ, Kuo CC. Arterioscler Thromb Vasc Biol; 2019 Mar 24; 39(3):432-445. PubMed ID: 30626205 [Abstract] [Full Text] [Related]
16. Effects of Enterococcus faecalis lipoteichoic acid on receptor activator of nuclear factor-κB ligand and osteoprotegerin expression in periodontal ligament fibroblasts. Zhao L, Chen J, Cheng L, Wang X, Du J, Wang F, Peng Z. Int Endod J; 2014 Feb 24; 47(2):163-72. PubMed ID: 23710898 [Abstract] [Full Text] [Related]
17. No influence of OPG and its ligands, RANKL and TRAIL, on proliferation and regulation of the calcification process in primary human vascular smooth muscle cells. Olesen M, Skov V, Mechta M, Mumm BH, Rasmussen LM. Mol Cell Endocrinol; 2012 Oct 15; 362(1-2):149-56. PubMed ID: 22698523 [Abstract] [Full Text] [Related]
18. Histamine contributes to increased RANKL to osteoprotegerin ratio through altered nuclear receptor 4A activity in human chondrocytes. Marzaioli V, McMorrow JP, Angerer H, Gilmore A, Crean D, Zocco D, Rooney P, Veale D, Fearon U, Gogarty M, McEvoy AN, Stradner MH, Murphy EP. Arthritis Rheum; 2012 Oct 15; 64(10):3290-301. PubMed ID: 22674155 [Abstract] [Full Text] [Related]
19. Regulation of RANKL by biomechanical loading in fibrochondrocytes of meniscus. Deschner J, Wypasek E, Ferretti M, Rath B, Anghelina M, Agarwal S. J Biomech; 2006 Oct 15; 39(10):1796-803. PubMed ID: 16038916 [Abstract] [Full Text] [Related]
20. Estrogen inhibits vascular calcification via vascular RANKL system: common mechanism of osteoporosis and vascular calcification. Osako MK, Nakagami H, Koibuchi N, Shimizu H, Nakagami F, Koriyama H, Shimamura M, Miyake T, Rakugi H, Morishita R. Circ Res; 2010 Aug 20; 107(4):466-75. PubMed ID: 20595654 [Abstract] [Full Text] [Related] Page: [Next] [New Search]